INmune Bio, Inc. (INMB) Tops Q3 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Nasdaq falls as Alphabet set for record loss amid AI spending woes
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts INMB Hot Sheet
Join SI Premium – FREE
INmune Bio, Inc. (NASDAQ: INMB) reported Q3 EPS of ($0.24), $0.09 better than the analyst estimate of ($0.33).
For earnings history and earnings-related data on INmune Bio, Inc. (INMB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- First US Bancshares (FUSB) Reports Q3 EPS of $0.36
- Oppenheimer Reiterates Outperform Rating on Tyler Tech (TYL)
- Exlservice (EXLS) PT Raised to $48 at Stifel
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
